Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases

Details for Australian Patent Application No. 2004253888 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Schultz, Jeffrey; Gilson, Charles III; Smith, Jeffrey; Smith, Brian

Agent FB Rice

Pub. Number AU-B-2004253888

PCT Pub. Number WO2005/003096

Priority 60/479,280 17.06.03 US

Filing date 16 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 11 November 2010

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/003096 Priority application(s): WO2005/003096

11 November 2010 Application Accepted

  Published as AU-B-2004253888

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253889-Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor

2004253884-SPPLs as modifiers of the p53 pathway and methods of use